Inconsistent state immunization laws complicate pharmacy operations and limit patient access.
|Articles|May 1, 2007
- Volume 0 0
MYLAN BARRED FROM SELLING GENERIC TOPAMAX
Advertisement
A federal judge in NewJersey issued an injunctionpermanently barringMylan Pharmaceuticalsfrom selling generic topiramatetablets and capsulesin the United Statesbefore September 26,2008, the expiration dateof the patent for TOPAMAX(topiramate) heldby Ortho-McNeil NeurologicsInc. Mylan hadchallenged the validity ofthat patent and filed anabbreviated new drugapplication to market ageneric version of theepilepsy drug. The brandedmanufacturer counteredwith a patentinfringement complaintagainst Mylan and obtaineda preliminary injunctionagainst the genericfirm last fall.
Articles in this issue
over 19 years ago
can you READ these Rxs?over 19 years ago
compounding HOTLINEover 19 years ago
Pseudoephedrine Logs Need Constant Tendingover 19 years ago
Another Federal Court Rejects a Drug Importation Planover 19 years ago
Home Infusion Therapy Gets Patients Out of the Hospitalover 19 years ago
RESPy AWARD: Teamwork Is the Thread That Bindsover 19 years ago
Child-resistant Does Not Mean Childproofover 19 years ago
ccpa SPEAKS OUT: CCPA Works to Improve Medicare Part Dover 19 years ago
Genetic Testing: Remarkable Resource or Invasion of Privacy?over 19 years ago
case STUDIESAdvertisement
Related to this article
OCEANIC-STROKE supports a potential additional antithrombotic approach for select patients after noncardioembolic stroke or high-risk TIA.
Garlic has a long history in traditional medicine, but evidence for its benefits varies by preparation, and patients taking medications that increase bleeding risk should use it with caution.
The costs to patients, their families, their workplaces, and their communities go well beyond dollars and cents.
Across every setting, the pharmacist's role is to build reliable systems around patients so stroke prevention remains safe and sustainable across the care continuum.
Pharmacists can plan career sabbaticals before retirement with smart savings, employer leave options, and intentional steps that balance their finances with their goals.
Like enzymes and coenzymes, monitoring devices and pharmacists may achieve more together than either can alone.
Every responsibility described in this issue depends on a pharmacy workforce with enough time and support to carry it.
Advertisement
Advertisement
Trending on Pharmacy Times
1
mRNA vs Protein-Based COVID-19 Vaccines: What Pharmacists Can Tell Patients
2
Asundexian Receives FDA Approval, Becomes First FXIa Inhibitor for Secondary Stroke Risk Reduction
3
FDA Reportedly Shelves Commissioner's National Priority Voucher Program
4
Inside the OCEANIC-STROKE Trial and What Asundexian Means for the Future of Stroke Prevention
5